The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Chronic Nicotine Differentially Regulates α6- and β3-Containing Nicotinic Cholinergic Receptors in Rat Brain
Abstract
We investigated the effects of chronic nicotine on alpha6- and beta3-containing nicotinic acetylcholine receptors (nAChRs) in two rat brain regions using three methodological approaches: radioligand binding, immunoprecipitation, and nicotine-stimulated synaptosomal release of dopamine. Nicotine was administered by osmotic minipumps for 2 weeks. Quantitative autoradiography with [(125)I]alpha-conotoxin MII to selectively label alpha6(*) nAChRs showed a 28% decrease in binding in the striatum but no change in the superior colliculus. Immunoprecipitation of nAChRs labeled by [(3)H]epibatidine in these two regions showed that chronic nicotine increased alpha4- and beta2-containing nAChRs by 39 to 67%. In contrast, chronic nicotine caused a 39% decrease in alpha6-containing nAChRs in striatum but no change in superior colliculus. No changes in beta3-containing nAChRs were seen in either region after chronic nicotine. The decreased expression of alpha6-containing nAChRs persisted for at least 3 days, recovering to baseline by 7 days after removal of the pumps. There was a small but significant decrease in total nicotine-stimulated dopamine release in striatal synaptosomes after nicotine exposure. However, the component of dopamine release that was resistant to alpha-conotoxin MII blockade was unaffected, whereas dopamine release that was sensitive to blockade by alpha-conotoxin MII was decreased by 56%. These findings indicate that the alpha6(*) nAChR is regulated differently from other nAChR subtypes, and they suggest that the inclusion of a beta3 subunit with alpha6 may serve to inhibit nicotine-induced down-regulation of these receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The effects of β3 on receptor trafficking and upregulation may help explain why in the striatum α6-containing receptors without β3 are downregulated by nicotine, while those containing β3 are unaffected (Perry et al. 2007).”
From Nicotine Withdrawal (2015) · cites this paper as Perry et al. 2007
In the citing paper
“While this prediction is straightforward, testing it has been confounded by the observation that different brain regions and nAChR subtypes have different upregulation parameters (Collins et al., 1989; Mao et al., 2008; Perry et al., 2007) and a lack of understanding of which brain regions are critically involved in specific withdrawal symptoms.”
From The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation (2012) · cites this paper as Perry et al., 2007
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Self-citationCorrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 512
Self-citationA New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489
Self-citationNicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479
Self-citationEffects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407
Self-citationSalminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401
Self-citation
Cited by
Sorted by citations
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Conus Venom Peptide Pharmacology
Lewis, R. J., Dutertre, S., Vetter, I., & Christie, M. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005322 · Cited by 434
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
Discovery, Synthesis, and Structure–Activity Relationships of Conotoxins
Akondi, K. B., Muttenthaler, M., Dutertre, S., Kaas, Q., Craik, D. J., Lewis, R. J., & Alewood, P. F. (2014) · Chemical Reviews · doi:10.1021/cr400401e · Cited by 330
Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 271
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197
Self-citationRoles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors
Azam, L., & McIntosh, J. M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.47 · Cited by 179
Self-citationMcLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 191
Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., & Lester, H. A. (2011) · Journal of General Physiology · doi:10.1085/jgp.201010532 · Cited by 169
Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability
Fowler, C. D., & Kenny, P. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.008 · Cited by 176
Conotoxins Targeting Nicotinic Acetylcholine Receptors: An Overview
Lebbe, E. K. M., Peigneur, S., Wijesekara, I., & Tytgat, J. (2014) · Marine Drugs · doi:10.3390/md12052970 · Cited by 163
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Assembly and trafficking of nicotinic acetylcholine receptors (Review)
Millar, N. S., & Harkness, P. C. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802035675 · Cited by 143
Multiple roles for nicotine in Parkinson's disease
Quik, M., Huang, L. Z., Parameswaran, N., Bordia, T., Campos, C., & Perez, X. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.003 · Cited by 137
Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133
Self-citationDoura, M. B., Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.056 · Cited by 129
Self-citationNeurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 121
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 117
Self-citationPistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 120
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 109
Grady, S. R., Drenan, R. M., Breining, S. R., Yohannes, D., Wageman, C. R., Fedorov, N. B., McKinney, S., Whiteaker, P., Bencherif, M., Lester, H. A., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.013 · Cited by 98
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 97
Huang, L. Z., Parameswaran, N., Bordia, T., McIntosh, J. M., & Quik, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06011.x · Cited by 94
Self-citationEgleton, R. D., Brown, K. C., & Dasgupta, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.007 · Cited by 91
Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78
Counotte, D. S., Smit, A. B., Pattij, T., & Spijker, S. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.05.010 · Cited by 77
Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77
Self-citationAzam, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10-166272 · Cited by 77
Self-citationToll, L., Zaveri, N. T., Polgar, W. E., Jiang, F., Khroyan, T. V., Zhou, W., Xie, X., Stauber, G. B., Costello, M. R., & Leslie, F. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.322 · Cited by 80
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 83
Greenbaum, L., & Lerer, B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.59 · Cited by 73
Marks, M. J., McClure-Begley, T. D., Whiteaker, P., Salminen, O., Brown, R. W. B., Cooper, J., Collins, A. C., & Lindstrom, J. M. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178236 · Cited by 70
An α7 nicotinic receptor-G protein pathway complex regulates neurite growth in neural cells*
Nordman, J. C., & Kabbani, N. (2012) · Journal of Cell Science · doi:10.1242/jcs.110379 · Cited by 69
Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
Srinivasan, R., Henderson, B. J., Lester, H. A., & Richards, C. I. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.005 · Cited by 67
Nicotinic receptors regulate the dynamic range of dopamine release in vivo
Koranda, J. L., Cone, J. J., McGehee, D. S., Roitman, M. F., Beeler, J. A., & Zhuang, X. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00269.2013 · Cited by 68
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Moretti, M., Mugnaini, M., Tessari, M., Zoli, M., Gaimarri, A., Manfredi, I., Pistillo, F., Clementi, F., & Gotti, C. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064071 · Cited by 58
Gould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W., Yildirim, E., & Adoff, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.003 · Cited by 56
“…it has been confounded by the observation that different brain regions and nAChR subtypes have different upregulation parameters (Collins et al., 1989; Mao et al., 2008; Perry et al., 2007) and a lack of understanding of which brain regions are critically involved in specific withdrawal symptoms.”
Nicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 57
Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy-Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12251 · Cited by 58
Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.076 · Cited by 55
Self-citationNicotine: Alcohol Reward Interactions
Lajtha, Á., & Sershen, H. W. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0181-8 · Cited by 57
Nicotine and Behavioral Sensitization
Mao, D., & McGehee, D. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9230-7 · Cited by 50
Self-citationCotinine selectively activates a subpopulation of α3/α6β2* nicotinic receptors in monkey striatum
O’Leary, K., Parameswaran, N., McIntosh, J. M., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136838 · Cited by 45
Self-citationAzam, L., Yoshikami, D., & McIntosh, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710288200 · Cited by 44
Self-citationNicotinic Acetylcholine Receptor Subunits in Rhesus Monkey Retina
Liu, J., McGlinn, A. M., Fernandes, A., Milam, A., Strang, C. E., Andison, M., Lindstrom, J., Keyser, K., & Stone, R. (2008) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.08-2398 · Cited by 42
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Gold, A. B., & Lerman, C. E. (2012) · Human Genetics · doi:10.1007/s00439-012-1143-9 · Cited by 41
Self-citationGarção, P., Szabó, E. C., Wopereis, S., de Castro, A. A., Tomé, Â. R., Prediger, R. D., Cunha, R. A., Agostinho, P. M., & Köfalvi, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12234 · Cited by 40
Lomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., & Kellar, K. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07408.x · Cited by 37
Self-citationRole for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice
Quik, M., Park, K. M., Hrachova, M., Mallela, A., Huang, L. Z., McIntosh, J. M., & Grady, S. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.029 · Cited by 37
Self-citationMarks, M. J., Grady, S. R., Salminen, O., Paley, M. A., Wageman, C. R., McIntosh, J. M., & Whiteaker, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12721 · Cited by 37
Self-citationCox, B. C., Marritt, A. M., Perry, D. C., & Kellar, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05282.x · Cited by 43
Self-citationAT ‐1001: a high‐affinity α3β4 nAChR ligand with novel nicotine‐suppressive pharmacology
Cippitelli, A., Wu, J., Gaiolini, K. A., Mercatelli, D., Schoch, J., Gorman, M., Muñoz, A. R., Ciccocioppo, R., Khroyan, T. V., Yasuda, D. M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13034 · Cited by 38
Hussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34
Self-citationWu, J., Zhang, Y., Maida, L. E., Santos, R. G., Welmaker, G. S., Lavoi, T. M., Nefzi, A., Yu, Y., Houghten, R. A., Toll, L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401543h · Cited by 31
Moen, J. K., & Lee, A. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.745783 · Cited by 30
Native α6β4∗ nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland
Pérez‐Alvarez, A., Hernández‐Vivanco, A., McIntosh, J. M., & Albillos, A. (2011) · The FASEB Journal · doi:10.1096/fj.11-190223 · Cited by 29
Self-citationWooters, T. E., Smith, A. M., Pivavarchyk, M., Siripurapu, K. B., McIntosh, J. M., Zhang, Z., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01220.x · Cited by 28
Self-citationFox-Loe, A. M., Moonschi, F. H., & Richards, C. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661827 · Cited by 27
Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 27
DeDominicis, K. E., Sahibzada, N., Olson, T. T., Xiao, Y., Wolfe, B. B., Kellar, K. J., & Yasuda, R. P. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106880 · Cited by 24
Self-citationTobacco addiction: A biochemical model of nicotine dependence
Ortells, M. O., & Barrantes, G. E. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.11.004 · Cited by 26
Ueda, M., Iida, Y., Tominaga, A., Yoneyama, T., Ogawa, M., Magata, Y., Nishimura, H., Kuge, Y., & Saji, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00613.x · Cited by 24
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 23
Self-citationBordia, T., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12179 · Cited by 23
Self-citationYou, S., Li, X., Xiong, J., Zhu, X., Zhangsun, D., Zhu, X., & Luo, S. (2019) · Marine Drugs · doi:10.3390/md17090490 · Cited by 22
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 21
Review: Nicotinic receptors and stages of nicotine dependence
Brennan, K., Lea, R. A., Fitzmaurice, P. S., & Truman, P. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100256 · Cited by 22
Quik, M., Campos, C., Parameswaran, N., Langston, J. W., McIntosh, J. M., & Yeluashvili, M. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9265-9 · Cited by 18
Self-citationGao, Y., Peng, S., Wen, Q., Zheng, C., Lin, J., Tan, Y., Ma, Y., Luo, Y., Xue, Y.-X., Wu, P., et al. (2014) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000650 · Cited by 18
Hoegberg, B. G., Lomazzo, E., Lee, N. H., & Perry, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.015 · Cited by 17
Self-citationBordia, T., McGregor, M., McIntosh, J. M., Drenan, R. M., & Quik, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.040 · Cited by 17
Self-citationBeckmann, J. S., Meyer, A. C., Pivavarchyk, M., Horton, D. B., Zheng, G., Smith, A. M., Wooters, T. E., McIntosh, J. M., Crooks, P. A., Bardo, M. T., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1680-4 · Cited by 18
Self-citationEffects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro
Reid, R. T., & Sabbagh, M. N. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0107-7 · Cited by 16
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 16
Self-citationQuantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus
Lomazzo, E., MacArthur, L. H., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06967.x · Cited by 15
Self-citationSmith, A. M., Pivavarchyk, M., Wooters, T. E., Zhang, Z., Zheng, G., McIntosh, J. M., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.018 · Cited by 15
Self-citationAbreu‐Villaça, Y., Correa‐Santos, M., Dutra-Tavares, A. C., Paes‐Branco, D., Nunes‐Freitas, A. L., Manhães, A. C., Filgueiras, C. C., & Ribeiro‐Carvalho, A. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.06.002 · Cited by 15
Cholinergic Responses in Crossed Tecto-Reticular Neurons of Rat Superior Colliculus
Sooksawate, T., Isa, K., & Isa, T. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90723.2008 · Cited by 15
Regional differential effects of chronic nicotine on brain α4-containing and α6-containing receptors
Even, N., Cardona, A., Soudant, M., Corringer, P., Changeux, J., & Cloëz-Tayarani, I. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283112703 · Cited by 14
Yang, K., McLaughlin, I., Shaw, J. K., Cardé, N. A. Q., Dani, J. A., & Biasi, M. D. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109547 · Cited by 12
Kucinski, A., Wersinger, S., Stachowiak, E., Corso, T. D., Parry, M., Zhang, J., Jordan, K., Letchworth, S., Bencherif, M., & Stachowiak, M. (2013) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.005 · Cited by 13
Nguyen, J., Ghazali, R., Batterham, P., & Perry, T. (2021) · Pest Management Science · doi:10.1002/ps.6290 · Cited by 13
Wu, J., Cippitelli, A., Zhang, Y., Debevec, G., Schoch, J., Ozawa, A., Yu, Y., Liu, H., Chen, W., Houghten, R. A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01250 · Cited by 13
Sooksawate, T., Yanagawa, Y., & Isa, T. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08169.x · Cited by 8
Saba, W., Valette, H., Granon, S., Xiao, Y., Kellar, K. J., Dollé, F., & Bottlaender, M. (2010) · Synapse · doi:10.1002/syn.20776 · Cited by 7
Self-citationFox-Loe, A. M., Dwoskin, L. P., & Richards, C. I. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_7 · Cited by 5
Baladi, M. G., Nielsen, S. M., McIntosh, J. M., Hanson, G. R., & Fleckenstein, A. E. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000215 · Cited by 4
Self-citationRogers, S. W., & Gahring, L. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143319 · Cited by 3
Presynaptic Nicotinic Acetylcholine Receptors: Subtypes and Functions
Marks, M. J., Grady, S. R., McClure‐Begley, T. D., O’Neill, H. C., & Zambrano, C. A. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_4 · Cited by 1
Contribution of Variants in CHRNB3/A6 Gene Cluster on Chromosome 8 to Smoking Dependence
Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_6 · Cited by 1
Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64
Nastrucci, C., & Russo, P. (2012) · InTech eBooks · doi:10.5772/33216 · Cited by 1
Alzahrani, H. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Salmelainen, L. (2010) · Työväentutkimus Vuosikirja
The Role of Medial Habenula-Interpeduncular Nucleus Pathway in Anxiety: A Dissertation
Pang, X.-Y. (2015) · eScholarship@UMassChan · doi:10.13028/m2vp49
Metadata
- Authors
- Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J.
- Affiliations
- George Washington University (US)
- Georgetown University (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 322
- Issue
- 1
- Pages
- 306-315
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2147542109
- Semantic Scholar
- 80efc9963d81a0ba4b0eb2793a4a416178bc42a1
- Cited by
- 106
- References
- 56
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 7 · 2015: 10 · 2014: 10 · 2013: 10 · 2012: 11
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Utah
- National Institute of Mental Health (MH53631, R01MH053631)
- National Institute on Drug Abuse (DA012976, R01DA015767, R01DA012242, DA015767, DA12242)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic nicotine, nicotinic acetylcholine receptors, alpha6 subunit, beta3 subunit, receptor down-regulation, striatum, superior colliculus, dopamine release, alpha-conotoxin MII, epibatidine, receptor subunit expression, nicotine withdrawal
- MeSH terms
- Amino Acid Sequence, Animals, Autoradiography, Brain, Dopamine, Male, Molecular Sequence Data, Nicotine, Receptors, Nicotinic, Rats, Sprague-Dawley, Conotoxins, Immunoprecipitation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review